InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

爱朋医疗 (300753.SZ) — directors' dealings · MAR Art. 19 · 9 reports

← Companies ★ Sign in to follow

爱朋医疗: directors' dealings · France · AMF

SZSE:300753FRFR·AMFMcap 3.5Bn€

Explore the full directors' dealings record of 爱朋医疗, a listed equity based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €3.5bn. The latest transaction was filed on 11 August 2025 — Sale. Among the most active insiders: 李庆. Every trade is openly available.

9

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

·

8 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

27.01 €

Income statement

Revenue342.0 M€

Gross profit234.1 M€68% margin

Net income−24.0 M€-7.0% margin

Balance sheet & cash

Market cap3.50 Bn€

Total debt118.6 M€

Free Cash Flow−6.1 M€

Last declaration on 11 August 2025

All Executives9 Thresholds Prospectus Other

Declarations9 total

Executives●Sale11SZSE

李

李庆高管

14,900 shares

A股XSHE

SZSE:173000009340961340·11 Aug 2025

Executives●Sale11SZSE

李

李庆高管

89,300 shares

A股XSHE

SZSE:173000009337089820·8 Aug 2025

Executives●Purchase11SZSE

朱

朱红毅高管

20,000 shares

A股XSHE

SZSE:173000007890860480·26 Jul 2024

Ideal exit: 22 Apr 2025 (T+270)

Executives●Sale22SZSE

张

张智慧董事,总经理

2,410,000 shares

A股XSHE

SZSE:173000005699580300·20 Jul 2022

Executives●Sale7SZSE

关

关继峰董事

17,000 shares

A股XSHE

SZSE:173000005658098200·4 Jul 2022

Executives●Sale7SZSE

顾

顾爱军监事

114,576 shares

A股XSHE

SZSE:173000005602401180·17 Jun 2022

Executives●Sale7SZSE

王

王凝宇董事

250,000 shares

A股XSHE

SZSE:173000005602401150·17 Jun 2022

Executives●Sale7SZSE

王

王凝宇董事

600,000 shares

A股XSHE

SZSE:173000005584468860·10 Jun 2022

Executives●Sale7SZSE

关

关继峰董事

7,800 shares

A股XSHE

SZSE:173000004531281400·29 Jun 2021

9 of 9 declarations